<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ophthalmology</journal-id><journal-title-group><journal-title xml:lang="ru">Офтальмология</journal-title><trans-title-group xml:lang="en"><trans-title>Ophthalmology in Russia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1816-5095</issn><issn pub-type="epub">2500-0845</issn><publisher><publisher-name>Ophthalmology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18008/1816-5095-2026-1-150-156</article-id><article-id custom-type="elpub" pub-id-type="custom">ophthalmology-2886</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Влияние очковой коррекции с линзами дефокусного дизайна на прогрессирование миопии у детей и подростков</article-title><trans-title-group xml:lang="en"><trans-title>The Effect of Eyeglass Correction with Defocus Design Lenses on the Progression of Myopia in Children and Adolescents</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-1987-5737</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мягков</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Myagkov</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мягков Даниил Александрович – врач‑ординатор кафедры офтальмологии </p><p>ул. Россолимо, 11а, б, Москва, 119021</p></bio><bio xml:lang="en"><p>Myagkov Daniil A., resident physician at the Ophthalmology Department </p><p>Rossolimo str., 11a, b, Moscow, 119021</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0001-4563-3069</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чудинова</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Chudinova</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чудинова Валерия Ильинична – врач‑офтальмолог, научный сотрудник отдела контроля миопии </p><p>ул. Дегунинская, 7, Москва, 127486</p></bio><bio xml:lang="en"><p>Chudinova Valeriya I., ophthalmologist, researcher of the Myopia Control Department</p><p>Deguninskaya str., 7, Moscow, 127486</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт глазных болезней им. М.М. Краснова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Krasnov Research Institute of Eye Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>АНО «Национальный институт миопии»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Myopia Institute</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>29</day><month>03</month><year>2026</year></pub-date><volume>23</volume><issue>1</issue><fpage>150</fpage><lpage>156</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Мягков Д.А., Чудинова В.И., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Мягков Д.А., Чудинова В.И.</copyright-holder><copyright-holder xml:lang="en">Myagkov D.A., Chudinova V.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.ophthalmojournal.com/opht/article/view/2886">https://www.ophthalmojournal.com/opht/article/view/2886</self-uri><abstract><sec><title>Актуальность</title><p>Актуальность. Прогрессирующая миопия остается серьезной медико-социальной проблемой, требующей эффективных методов ее стабилизации. Перспективным неинвазивным подходом являются очки с дефокусным дизайном DIMS, замедляющие аксиальный рост глаза. Сравнительные исследования научно обоснованных методов позволяют выбирать оптимальные стратегии контроля миопии для различных групп пациентов. Настоящая работа представляет собой часть более масштабного проекта, направленного на оценку эффективности таких методов. </p></sec><sec><title>Цель исследования</title><p>Цель исследования: изучить влияние очков с DIMS-линзами на прогрессирование миопии у детей и подростков по показателям аксиальной длины (AL) и сфероэквивалента (SE) в течение 12 месяцев. </p></sec><sec><title>Пациенты и методы</title><p>Пациенты и методы. В исследование включены 63 ребенка 7–14 лет с миопией слабой и средней степени (SE от -0,50 до -6,00 D). Пациенты самостоятельно выбирали метод коррекции: трансфокальные очки, ортокератология или мягкие бифокальные линзы. Группу исследования составили те, кто выбрал очки с DIMS. AL и SE измерялись на входе в исследование и через 12 месяцев. Проводилась стратификация по степени миопии. </p></sec><sec><title>Результаты</title><p>Результаты. За один год средний прирост AL составил 0,16 ± 0,06 мм, SE — 0,31 ± 0,08 D. При слабой миопии выявлена умеренная положительная корреляция между AL и SE (r = +0,372, p = 0,0276); при средней степени корреляция отсутствовала. Отказ от очков (28,6 %) чаще был связан с переходом на МКЛ (мягкие контактные линзы) с дефокусом или ОКЛ (ортокератологические контактные линзы). </p></sec><sec><title>Заключение</title><p>Заключение. Очки с DIMS-линзами оказались эффективными в замедлении прогрессирования миопии. У пациентов со слабой миопией выявлена умеренная положительная корреляция между динамикой аксиальной длины и сфероэквивалентом, в отличие от группы со средней миопией, что может указывать на различия в механизмах прогрессии. Отказ от очков чаще был связан с переходом на альтернативные методы коррекции (МКЛ с дефокусом или ОКЛ), что подчеркивает важность индивидуального подхода и возможности выбора лечения для повышения приверженности терапии.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Progressive myopia remains a serious medical and social problem that requires effective methods of its stabilization.</p><p>A promising non-invasive approach is glasses with a defocused DIMS design that slow down the axial growth of the eye. Comparative studies of evidence-based methods allow selection of optimal control strategies for different patient groups. The present work is part of a large project aimed at evaluating such methods.</p></sec><sec><title> Purpose</title><p> Purpose: to study the effect of DIMS glasses on myopia progression in children and adolescents by axial length (AL) and spheroequivalent (SE) scores over 12 months. </p></sec><sec><title>Patients and methods</title><p>Patients and methods. The study included 63 children 7–14 years old with mild to moderate myopia (-0.50 D to -6.00 D). Patients independently chose the method of correction: transfocal glasses, orthokeratology or soft bifocal lenses. The study group consisted of those who chose glasses with DIMS. AL and SE were measured at baseline and 12 months. Myopia was stratified. </p></sec><sec><title>Results</title><p>Results. Over the year, the average increase in AL was</p></sec><sec><title>0</title><p>0.16 ± 0.06 mm, SE — 0.31 ± 0.08 D. With mild myopia, a moderate positive correlation was found between AL and SE (r = +0.372, p = 0.0276); with a moderate degree — no. Refusal of points (28.6%) was more often associated with the transition to MCL with defocus or OCL. </p></sec><sec><title>Conclusions</title><p>Conclusions. Glasses with DIMS lenses were effective in slowing the progression of myopia. Patients with mild myopia showed a moderate positive correlation between axial length and spheroequivalent, in contrast to the group with moderate myopia, which may indicate differences in the mechanisms of progression. Refusal of glasses was more often associated with the transition to alternative methods of correction (MCL with defocus or OCL), emphasizing the importance of an individual approach and the possibility of choice to increase adherence to therapy.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>контроль миопии</kwd><kwd>трансфокальные очки</kwd><kwd>технология DIMS</kwd><kwd>аксиальная длина</kwd><kwd>сферический эквивалент</kwd></kwd-group><kwd-group xml:lang="en"><kwd>myopia control</kwd><kwd>transfocal glasses</kwd><kwd>DIMS technology</kwd><kwd>axial length</kwd><kwd>spherical equivalent</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ang M, Wong TY. A Clinical Perspective Updates on Myopia. Springer Open. 2020. doi: 10.1007/978-981-13-8491-2.</mixed-citation><mixed-citation xml:lang="en">Ang M, Wong TY. A Clinical Perspective Updates on Myopia. Springer Open. 2020. doi: 10.1007/978-981-13-8491-2.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Myagkov AV, Myagkov DA. Optical methods for the management of progressive myopia. Eye Glaz. 2023;25(2):151–162. doi: 10.33791/2222-4408-2023-2-151-162.</mixed-citation><mixed-citation xml:lang="en">Myagkov AV, Myagkov DA. Optical methods for the management of progressive myopia. Eye Glaz. 2023;25(2):151–162. doi: 10.33791/2222-4408-2023-2-151-162.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Zadnik K, Sinnott LT, Cotter SA, Jones-Jordan LA, Kleinstein RN, Manny RE, Twelker JD, Mutti DO. Prediction of juvenile-onset myopia. JAMA Ophthalmol. 2015;133(6):683–689. doi: 10.1001/jamaophthalmol.2015.0471.</mixed-citation><mixed-citation xml:lang="en">Zadnik K, Sinnott LT, Cotter SA, Jones-Jordan LA, Kleinstein RN, Manny RE, Twelker JD, Mutti DO. Prediction of juvenile-onset myopia. JAMA Ophthalmol. 2015;133(6):683–689. doi: 10.1001/jamaophthalmol.2015.0471.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Saw SM, Gazzard G, Shin-Yen EC, Chua WH. Myopia and associated pathological complications. Ophthalmic and Physiological Optics. 2005;25(5):381–391. doi: 10.1111/j.1475-1313.2005.00298.x.</mixed-citation><mixed-citation xml:lang="en">Saw SM, Gazzard G, Shin-Yen EC, Chua WH. Myopia and associated pathological complications. Ophthalmic and Physiological Optics. 2005;25(5):381–391. doi: 10.1111/j.1475-1313.2005.00298.x.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2012;31(6):622–660. doi: 10.1016/j.preteyeres.2012.06.004.</mixed-citation><mixed-citation xml:lang="en">Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2012;31(6):622–660. doi: 10.1016/j.preteyeres.2012.06.004.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Wong TY, Ferreira A, Hughes R, Carter G, Mitchell P. Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: An evidencebased systematic review. Am J Ophthalmol. 2014;157(1):9–25.e12. doi: 10.1016/j.ajo.2013.08.010.</mixed-citation><mixed-citation xml:lang="en">Wong TY, Ferreira A, Hughes R, Carter G, Mitchell P. Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: An evidencebased systematic review. Am J Ophthalmol. 2014;157(1):9–25.e12. doi: 10.1016/j.ajo.2013.08.010.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, Wong TY, Naduvilath TJ, Resnikoff S. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036– 1042. doi: 10.1016/j.ophtha.2016.01.006.</mixed-citation><mixed-citation xml:lang="en">Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, Wong TY, Naduvilath TJ, Resnikoff S. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036– 1042. doi: 10.1016/j.ophtha.2016.01.006.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Carlà MM, Boselli F, Giannuzzi F, Gambini G, Caporossi T, Vico UD, Savastano A, Baldascino A, Rizzo C, Kilian R, Rizzo S. Overview on Defocus Incorporated Multiple Segments Lenses: A Novel Perspective in Myopia Progression Management. Vision (Switzerland). 2022;6(2):20. doi: 10.3390/vision6020020.</mixed-citation><mixed-citation xml:lang="en">Carlà MM, Boselli F, Giannuzzi F, Gambini G, Caporossi T, Vico UD, Savastano A, Baldascino A, Rizzo C, Kilian R, Rizzo S. Overview on Defocus Incorporated Multiple Segments Lenses: A Novel Perspective in Myopia Progression Management. Vision (Switzerland). 2022;6(2):20. doi: 10.3390/vision6020020.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lam CSY, Tang WC, Tse DYY, Lee RPK, Chun RKM, Hasegawa K, Qi H, Hatanaka T, To CH. Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: A 2-year randomised clinical trial. British Journal of Ophthalmology. 2020;104(3):363–368. doi: 10.1136/bjophthalmol-2018-313739.</mixed-citation><mixed-citation xml:lang="en">Lam CSY, Tang WC, Tse DYY, Lee RPK, Chun RKM, Hasegawa K, Qi H, Hatanaka T, To CH. Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: A 2-year randomised clinical trial. British Journal of Ophthalmology. 2020;104(3):363–368. doi: 10.1136/bjophthalmol-2018-313739.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Jaskulski M, Singh NK, Bradley A, Kollbaum PS. Optical and imaging properties of a novel multi-segment spectacle lens designed to slow myopia progression. Ophthalmic and Physiological Optics. 2020;40(5):549–556. doi: 10.1111/opo.12725.</mixed-citation><mixed-citation xml:lang="en">Jaskulski M, Singh NK, Bradley A, Kollbaum PS. Optical and imaging properties of a novel multi-segment spectacle lens designed to slow myopia progression. Ophthalmic and Physiological Optics. 2020;40(5):549–556. doi: 10.1111/opo.12725.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Gantes-Nuñez J, Jaskulski M, López-Gil N, Kollbaum PS. Optical characterisation of two novel myopia control spectacle lenses. Ophthalmic and Physiological Optics. 2023;43(3):388–401. doi: 10.1111/opo.13098.</mixed-citation><mixed-citation xml:lang="en">Gantes-Nuñez J, Jaskulski M, López-Gil N, Kollbaum PS. Optical characterisation of two novel myopia control spectacle lenses. Ophthalmic and Physiological Optics. 2023;43(3):388–401. doi: 10.1111/opo.13098.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Lam CSY, Tang WC, Lee PH, Zhang HY, Qi H, Hasegawa K, To CH. Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study. British Journal of Ophthalmology. 2022;106(8):1110–1114. doi: 10.1136/bjophthalmol-2020-317664.</mixed-citation><mixed-citation xml:lang="en">Lam CSY, Tang WC, Lee PH, Zhang HY, Qi H, Hasegawa K, To CH. Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study. British Journal of Ophthalmology. 2022;106(8):1110–1114. doi: 10.1136/bjophthalmol-2020-317664.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lam CSY, Tang WC, Zhang HY, Lee PH, Tse DYY, Qi H, Vlasak N, To CH. Longterm myopia control effect and safety in children wearing DIMS spectacle lenses for 6 years. Sci Rep. 2023;13(1):5475. doi: 10.1038/s41598-023-32700-7.</mixed-citation><mixed-citation xml:lang="en">Lam CSY, Tang WC, Zhang HY, Lee PH, Tse DYY, Qi H, Vlasak N, To CH. Longterm myopia control effect and safety in children wearing DIMS spectacle lenses for 6 years. Sci Rep. 2023;13(1):5475. doi: 10.1038/s41598-023-32700-7.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Keller K, Hessler P, Degle S. Longitudinale Studie zur Myopieprogression bei kaukasischen Studierenden unter Berücksichtigung der Achslänge des Auges und der objektiven Refraktion. Optometry &amp; Contact Lenses. 2024;4(4):133–142. doi: 10.54352/dozv. qqxm3780.</mixed-citation><mixed-citation xml:lang="en">Keller K, Hessler P, Degle S. Longitudinale Studie zur Myopieprogression bei kaukasischen Studierenden unter Berücksichtigung der Achslänge des Auges und der objektiven Refraktion. Optometry &amp; Contact Lenses. 2024;4(4):133–142. doi: 10.54352/dozv. qqxm3780.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Wang A, Yang C, Shen L, Wang J, Zhang Z, Yang W. Axial length shortening after orthokeratology and its relationship with myopic control. BMC Ophthalmol. 2022;22(1):243. doi: 10.1186/s12886-022-02461-4.</mixed-citation><mixed-citation xml:lang="en">Wang A, Yang C, Shen L, Wang J, Zhang Z, Yang W. Axial length shortening after orthokeratology and its relationship with myopic control. BMC Ophthalmol. 2022;22(1):243. doi: 10.1186/s12886-022-02461-4.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Akagun N, Altiparmak UE. Defocus incorporated multiple segments spectacle lenses for myopia control: A retrospective study in a Turkish cohort. Ophthalmic and Physiological Optics. 2025;45(5):1090–1097. doi: 10.1111/opo.13527.</mixed-citation><mixed-citation xml:lang="en">Akagun N, Altiparmak UE. Defocus incorporated multiple segments spectacle lenses for myopia control: A retrospective study in a Turkish cohort. Ophthalmic and Physiological Optics. 2025;45(5):1090–1097. doi: 10.1111/opo.13527.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Gupta V, Saxena R, Dhiman R, Phuljhele S, Sharma N. Comparative evaluation of different (peripheral defocus based) spectacle designs in preventing myopia progression: A double-blinded randomised clinical trial. Ophthalmic and Physiological Optics. Published online 2025. doi: 10.1111/opo.13548.</mixed-citation><mixed-citation xml:lang="en">Gupta V, Saxena R, Dhiman R, Phuljhele S, Sharma N. Comparative evaluation of different (peripheral defocus based) spectacle designs in preventing myopia progression: A double-blinded randomised clinical trial. Ophthalmic and Physiological Optics. Published online 2025. doi: 10.1111/opo.13548.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Lembo A, Schiavetti I, Serafi o M, Caputo R, Nucci P. Comparison of the performance of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) and highly aspherical lenslets (HAL) spectacles. BMJ Paediatr Open. 2024;8(1):e003187. doi: 10.1136/bmjpo-2024-003187.</mixed-citation><mixed-citation xml:lang="en">Lembo A, Schiavetti I, Serafi o M, Caputo R, Nucci P. Comparison of the performance of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) and highly aspherical lenslets (HAL) spectacles. BMJ Paediatr Open. 2024;8(1):e003187. doi: 10.1136/bmjpo-2024-003187.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
